SCHEMBL5500525

SCHEMBL5500525

O=C(OC1CCCC1(F)F)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
GAA P10253 1/20 0.43
CHRM2 P08172 2/20 0.43
CHRM4 P08173 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
LMNA P02545 2/20 0.40
F2 P00734 1/20 0.40
SLC18A3 Q16572 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PRKCA P17252 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5501580 1.00 CHRNA7 (0.44) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL27623429 1.00 CHRNA7 (0.44) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL9583294 0.81 TSHR (0.44) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL4809454 0.77 MEN1 (0.46) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL4147717 0.76 GAA (0.51) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL25521044 0.75 LMNA (0.54) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL6060883 0.75 GAA (0.47) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL4811022 0.75 HTR3E (0.43) CHRNA7KMT2AMEN1GAACHRM2
SCHEMBL1886968 0.74 MEN1 (0.56) CHRNA7KMT2AMEN1GAAHTR3E
SCHEMBL31036937 0.74 GAA (0.42) CHRNA7KMT2AMEN1GAACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1625123-A4 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS MERCK & CO INC (US) 2007-08-29 EP disclosed
EP-1625123-A2 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS Merck & Co., Inc. (US) 2006-02-15 EP disclosed
WO-2004103279-A2 3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS MERCK & CO., INC. (US) 2004-12-02 WO disclosed